Stocktoria

NeuroPace Inc NPCE

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-04-22

NeuroPace Inc statistics & valuation

Market cap$561.5M
P / S5.6×
P / B29.5×
Net margin-21.5%
Return on equity-112.8%
FCF margin-11.3%
Net debt$37.2M
Enterprise value USD$598.7M
Earnings yield EBIT/EV-2.7%
Return on capital-18.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-59.00% -79.90% -103.40% -50.40% -34.00% -21.50% 202020212022202320242025
Gross margin (%)
73.60% 74.00% 71.40% 73.60% 73.90% 77.20% 202020212022202320242025
Operating margin (%)
-31.70% -52.50% -89.60% -41.50% -27.10% -16.30% 202020212022202320242025
Return on equity (%)
-49.10% -135.40% -159.60% -338.70% -112.80% 202020212022202320242025
Shares outstanding
314096 24.5M 25.0M 27.8M 30.1M 33.6M 202020212022202320242025
Net debt ($)
$24.4M $30.7M $46.3M $38.9M $46.1M $37.2M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-43.40% -27.00% -41.30% -30.60% -28.70% -20.30% 202020212022202320242025
Free cash flow margin (%)
-52.70% -55.20% -82.30% -30.40% -22.80% -11.30% 202020212022202320242025
Debt / equity (×)
0.68× 1.52× 2.76× 7.43× 3.09× 202020212022202320242025
EPS ($)
-$117.85 -$2.17 -$1.91 -$1.27 -$0.93 -$0.66 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Gross margin77.2%73.9%73.6%71.4%74.0%73.6%
Operating margin-16.3%-27.1%-41.5%-89.6%-52.5%-31.7%
Net margin-21.5%-34.0%-50.4%-103.4%-79.9%-59.0%
FCF margin-11.3%-22.8%-30.4%-82.3%-55.2%-52.7%
Return on assets-20.3%-28.7%-30.6%-41.3%-27.0%-43.4%
Return on equity-112.8%-338.7%-159.6%-135.4%-49.1%16.4%
Debt / equity3.09×7.43×2.76×1.52×0.68×-0.34×
Current ratio5.285.375.718.9014.285.69

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.